|
1
|
Huang CY, Wei PL, Wang JW, Makondi PT,
Huang MT, Chen HA and Chang YJ: Glucose-regulated protein 94
modulates the response of osteosarcoma to chemotherapy. Dis
Markers. 2019:45697182019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Urciuoli E, Giorda E, Scarsella M, Petrini
S and Peruzzi B: Osteosarcoma-derived extracellular vesicles induce
a tumor-like phenotype in normal recipient cells. J Cell Physiol.
233:6158–6172. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li Y, Zeng C, Tu M, Jiang W, Dai Z, Hu Y,
Deng Z and Xiao W: MicroRNA-200b acts as a tumor suppressor in
osteosarcoma via targeting ZEB1. Onco Targets Ther. 9:3101–3111.
2016.PubMed/NCBI
|
|
4
|
Zhang Z, Luo G, Yu C, Yu G, Jiang R and
Shi X: MicroRNA-493-5p inhibits proliferation and metastasis of
osteosarcoma cells by targeting Kruppel-like factor 5. J Cell
Physiol. 234:13525–13533. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Corrò C and Moch H: Biomarker discovery
for renal cancer stem cells. J Pathol Clin Res. 4:3–18. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wahab SMR, Islam F, Gopalan V and Lam AK:
The identifications and clinical implications of cancer stem cells
in colorectal cancer. Clin Colorectal Cancer. 16:93–102. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yi M, Li J, Chen S, Cai J, Ban Y, Peng Q,
Zhou Y, Zeng Z, Peng S, Li X, Xiong W, Li G and Xiang B: Correction
to: Emerging role of lipid metabolism alterations in Cancer stem
cells. J Exp Clin Cancer Res. 37:1552018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jiang P, Zhang Y, Zhu C, Zhang W, Mao Z
and Gao C: Fe3O4/BSA particles induce
osteogenic differentiation of mesenchymal stem cells under static
magnetic field. Acta Biomater. 46:141–150. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Prasad P, Mittal SA, Chongtham J, Mohanty
S and Srivastava T: Hypoxia-mediated epigenetic regulation of
stemness in brain tumor cells. Stem Cells. 35:1468–1478. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin Q and Yun Z: Impact of the hypoxic
tumor microenvironment on the regulation of cancer stem cell
characteristics. Cancer Biol Ther. 9:949–956. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Couvelard A, O'Toole D, Turley H, Leek R,
Sauvanet A, Degott C, Ruszniewski P, Belghiti J, Harris AL, Gatter
K and Pezzella F: Microvascular density and hypoxia-inducible
factor pathway in pancreatic endocrine tumours: negative
correlation of microvascular density and VEGF expression with
tumour progression. Br J Cancer. 92:94–101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Z, Bao S, Wu Q, Wang H, Eyler C,
Sathornsumetee S, Shi Q, Cao Y, Lathia J, McLendon RE, et al:
Hypoxia-inducible factors regulate tumorigenic capacity of glioma
stem cells. Cancer Cell. 15:501–513. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim Y, Lin Q, Glazer PM and Yun Z: Hypoxic
tumor microenvironment and cancer cell differentiation. Curr Mol
Med. 9:425–434. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yuan G, Nanduri J, Khan S, Semenza GL and
Prabhakar NR: Induction of HIF-1alpha expression by intermittent
hypoxia: Involvement of NADPH oxidase, Ca2+ signaling,
prolyl hydroxylases, and mTOR. J Cell Physiol. 217:674–685. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin X, Sun B, Zhu D, Zhao X, Sun R, Zhang
Y, Zhang D, Dong X, Gu Q, Li Y, et al: Notch4+ cancer
stem-like cells promote the metastatic and invasive ability of
melanoma. Cancer Sci. 107:1079–1091. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fan Z, Li M, Chen X, Wang J, Liang X, Wang
H, Wang Z, Cheng B and Xia J: Prognostic value of cancer stem cell
markers in head and neck squamous cell carcinoma: a meta-analysis.
Sci Rep. 7:430082017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bradshaw A, Wickremsekera A, Tan ST, Peng
L, Davis PF and Itinteang T: Cancer stem cell hierarchy in
glioblastoma multiforme. Front Surg. 3:212016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang L, Park P, Zhang H, La Marca F and
Lin CY: Prospective identification of tumorigenic osteosarcoma
cancer stem cells in OS99-1 cells based on high aldehyde
dehydrogenase activity. Int J Cancer. 128:294–303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao Y, Zhao W, Lim YC and Liu T:
Salinomycin-loaded gold nanoparticles for treating cancer stem
cells by ferroptosis-induced cell death. Mol Pharm. 16:2532–2539.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zeng L, Cen Y and Chen J: Long non-coding
RNA MALAT-1 contributes to maintenance of stem cell-like phenotypes
in breast cancer cells. Oncol Lett. 15:2117–2122. 2018.PubMed/NCBI
|
|
22
|
Mukherjee S, Baidoo JNE, Sampat S, Mancuso
A, David L, Cohen LS, Zhou S and Banerjee P: Liposomal TriCurin, a
synergistic combination of curcumin, epicatechin gallate and
resveratrol, repolarizes tumor-associated microglia/macrophages,
and eliminates glioblastoma (GBM) and GBM stem cells. Molecules.
23:2012018. View Article : Google Scholar
|
|
23
|
Krishnapriya S, Sidhanth C, Manasa P,
Sneha S, Bindhya S, Nagare RP, Ramachandran B, Vishwanathan P,
Murhekar K, Shirley S, et al: Cancer stem cells contribute to
angiogenesis and lymphangiogenesis in serous adenocarcinoma of the
ovary. Angiogenesis. 22:441–455. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fourneaux B, Bourdon A, Dadone B, Lucchesi
C, Daigle SR, Richard E, Laroche-Clary A, Le Loarer F and Italiano
A: Identifying and targeting cancer stem cells in leiomyosarcoma:
Prognostic impact and role to overcome secondary resistance to
PI3K/mTOR inhibition. J Hematol Oncol. 12:112019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mohlin S, Wigerup C, Jögi A and Påhlman S:
Hypoxia, pseudohypoxia and cellular differentiation. Exp Cell Res.
356:192–196. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang P, Lan C, Xiong S, Zhao X, Shan Y, Hu
R, Wan W, Yu S, Liao B, Li G, et al: HIF1α regulates single
differentiated glioma cell dedifferentiation to stem-like cell
phenotypes with high tumorigenic potential under hypoxia.
Oncotarget. 8:28074–28092. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Maeda K, Ding Q, Yoshimitsu M, Kuwahata T,
Miyazaki Y, Tsukasa K, Hayashi T, Shinchi H, Natsugoe S and Takao
S: CD133 modulate HIF-1α expression under hypoxia in EMT phenotype
pancreatic cancer stem-like cells. Int J Mol Sci. 17:10252016.
View Article : Google Scholar
|
|
28
|
Bar EE, Lin A, Mahairaki V, Matsui W and
Eberhart CG: Hypoxia increases the expression of stem-cell markers
and promotes clonogenicity in glioblastoma neurospheres. Am J
Pathol. 177:1491–1502. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Conley SJ, Gheordunescu E, Kakarala P,
Newman B, Korkaya H, Heath AN, Clouthier SG and Wicha MS:
Antiangiogenic agents increase breast cancer stem cells via the
generation of tumor hypoxia. Proc Natl Acad Sci U S A.
109:2784–2789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guo Q, Lan F, Yan X, Xiao Z, Wu Y and
Zhang Q: Hypoxia exposure induced cisplatin resistance partially
via activating p53 and hypoxia inducible factor-1α in non-small
cell lung cancer A549 cells. Oncol Lett. 16:801–808.
2018.PubMed/NCBI
|
|
31
|
Yang ZL, Tian W, Wang Q, Zhao Y, Zhang YL,
Tian Y, Tang YX, Wang SJ, Liu Y, Ni QQ, et al: Oxygen-evolving
mesoporous organosilica coated prussian blue nanoplatform for
highly efficient photodynamic therapy of tumors. Adv Sci (Weinh).
5:17008472018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhao H, Wu Y, Chen Y and Liu H: Clinical
significance of hypoxia-inducible factor 1 and VEGF-A in
osteosarcoma. Int J Clin Oncol. 20:1233–1243. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Manresa MC and Taylor CT: Hypoxia
inducible factor (HIF) hydroxylases as regulators of intestinal
epithelial barrier function. Cell Mol Gastroenterol Hepatol.
3:303–315. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gorga A, Rindone G, Regueira M, Riera MF,
Pellizzari EH, Cigorraga SB, Meroni SB and Galardo MN: HIF
involvement in the regulation of rat Sertoli cell proliferation by
FSH. Biochem Biophys Res Commun. 502:508–514. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bao L, Chen Y, Lai HT, Wu SY, Wang JE,
Hatanpaa KJ, Raisanen JM, Fontenot M, Lega B, Chiang CM, et al:
Methylation of hypoxia-inducible factor (HIF)-1α by G9a/GLP
inhibits HIF-1 transcriptional activity and cell migration. Nucleic
Acids Res. 46:6576–6591. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Guo M, Cai C, Zhao G, Qiu X, Zhao H, Ma Q,
Tian L, Li X, Hu Y, Liao B, et al: Hypoxia promotes migration and
induces CXCR4 expression via HIF-1α activation in human
osteosarcoma. PLoS One. 9:e905182014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dodd KM, Yang J, Shen MH, Sampson JR, Tee
AR and KM D: mTORC1 drives HIF-1α and VEGF-A signalling via
multiple mechanisms involving 4E-BP1, S6K1 and STAT3. Oncogene.
34:2239–2250. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cornu M, Albert V, Hall MN and M C: mTOR
in aging, metabolism, and cancer. Curr Opin Genet Dev. 23:53–62.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Verheul HM, Salumbides B, Van Erp K,
Hammers H, Qian DZ, Sanni T, Atadja P and Pili R: Combination
strategy targeting the hypoxia inducible factor-1 alpha with
mammalian target of rapamycin and histone deacetylase inhibitors.
Clin Cancer Res. 14:3589–3597. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hou H, Miao J, Cao R, Han M, Sun Y, Liu X
and Guo L: Rapamycin ameliorates experimental autoimmune
encephalomyelitis by suppressing the mTOR-STAT3 pathway. Neurochem
Res. 42:2831–2840. 2017. View Article : Google Scholar : PubMed/NCBI
|
